D. Aletaha, T. Neogi, and A. Silman, 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1580-1588, 2010.
DOI : 10.1136/ard.2010.138461

URL : https://hal.archives-ouvertes.fr/hal-01557559

T. Theoharides, P. Valent, and C. Akin, Mast Cells, Mastocytosis, and Related Disorders, New England Journal of Medicine, vol.373, issue.2, pp.163-172, 2015.
DOI : 10.1056/NEJMra1409760

G. Cruse, D. Metcalfe, and A. Olivera, Functional Deregulation of KIT, Immunology and Allergy Clinics of North America, vol.34, issue.2, pp.219-237, 2014.
DOI : 10.1016/j.iac.2014.01.002

D. Magliacane, R. Parente, and M. Triggiani, Current concepts on diagnosis and treatment of mastocytosis, Transl Med UniSa, vol.8, pp.65-74, 2014.

L. Golkar and J. Bernhard, Mastocytosis, The Lancet, vol.349, issue.9062, pp.1379-1385, 1997.
DOI : 10.1016/S0140-6736(96)07056-0

E. Debruin, M. Gold, and B. Lo, Mast Cells in Human Health and Disease, Methods Mol Biol, vol.1220, pp.93-119, 2015.
DOI : 10.1007/978-1-4939-1568-2_7

T. Moon, S. Laurent, C. Morris, and K. , Advances in mast cell biology: new understanding of heterogeneity and function, Mucosal Immunology, vol.177, issue.2, pp.111-128, 2009.
DOI : 10.1074/jbc.M404318200

M. Gurish and J. Boyce, Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell, Journal of Allergy and Clinical Immunology, vol.117, issue.6, pp.1285-1291, 2006.
DOI : 10.1016/j.jaci.2006.04.017

J. Kalesnikoff and S. Galli, New developments in mast cell biology, Nature Immunology, vol.179, issue.11, pp.1215-1223, 2008.
DOI : 10.1038/nature07204

M. Urb and D. Sheppard, The Role of Mast Cells in the Defence against Pathogens, PLoS Pathogens, vol.65, issue.4, 2012.
DOI : 10.1371/journal.ppat.1002619.g001

S. Abraham, S. John, and A. , Mast cell-orchestrated immunity to pathogens, Nature Reviews Immunology, vol.173, issue.6, pp.440-452, 2010.
DOI : 10.4049/jimmunol.177.5.3294

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469150/pdf

S. Galli and M. Tsai, IgE and mast cells in allergic disease, Nature Medicine, vol.20, issue.5, pp.693-704, 2012.
DOI : 10.1016/S0167-5699(99)01535-2

G. Cruse and P. Bradding, Mast cells in airway diseases and interstitial lung disease, European Journal of Pharmacology, vol.778, 2015.
DOI : 10.1016/j.ejphar.2015.04.046

T. Moon, S. Laurent, C. Morris, and K. , Advances in mast cell biology: new understanding of heterogeneity and function, Mucosal Immunology, vol.177, issue.2, pp.111-128, 2009.
DOI : 10.1074/jbc.M404318200

S. Barete, N. Assous, and C. De-gennes, Systemic mastocytosis and bone involvement in a cohort of 75 patients, Annals of the Rheumatic Diseases, vol.69, issue.10, pp.1838-1841, 2009.
DOI : 10.1136/ard.2009.124511

URL : https://hal.archives-ouvertes.fr/hal-00528144

M. Biosse-duplan, B. Baroukh, and M. Dy, Histamine Promotes Osteoclastogenesis through the Differential Expression of Histamine Receptors on Osteoclasts and Osteoblasts, The American Journal of Pathology, vol.174, issue.4, pp.1426-1434, 2009.
DOI : 10.2353/ajpath.2009.080871

M. Rossini, R. Zanotti, and O. Viapiana, Zoledronic Acid in Osteoporosis Secondary to??Mastocytosis, The American Journal of Medicine, vol.127, issue.11, 2014.
DOI : 10.1016/j.amjmed.2014.06.015

N. Guillaume, J. Desoutter, and O. Chandesris, Bone Complications of Mastocytosis: A Link between Clinical and Biological Characteristics, The American Journal of Medicine, vol.126, issue.1, 2013.
DOI : 10.1016/j.amjmed.2012.07.018

URL : https://hal.archives-ouvertes.fr/hal-00844953

M. Laroche, C. Livideanu, C. Paul, and A. Cantagrel, Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis, The American Journal of Medicine, vol.124, issue.8, pp.776-778, 2011.
DOI : 10.1016/j.amjmed.2011.02.038

A. Marshall, R. Kavanagh, and A. Crisp, The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis, Rheumatology, vol.36, issue.3, pp.393-396, 1997.
DOI : 10.1093/rheumatology/36.3.393

C. Brumsen, N. Hamdy, and S. Papapoulos, Osteoporosis and Bone Marrow Mastocytosis: Dissociation of Skeletal Responses and Mast Cell Activity During Long-Term Bisphosphonate Therapy, Journal of Bone and Mineral Research, vol.36, issue.4, pp.567-569, 2002.
DOI : 10.1359/jbmr.2002.17.4.567

A. Lim, A. Ostor, S. Love, and A. Crisp, Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment, Annals of the Rheumatic Diseases, vol.64, issue.6, pp.965-966, 2004.
DOI : 10.1136/ard.2004.029116

J. Kay and K. Upchurch, ACR/EULAR 2010 rheumatoid arthritis classification criteria, Rheumatology, vol.62, issue.9, pp.5-9, 2012.
DOI : 10.1002/art.27580

URL : https://academic.oup.com/rheumatology/article-pdf/51/suppl_6/vi5/5056206/kes279.pdf

I. Gotis-graham and H. Mcneil, Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression, Arthritis & Rheumatism, vol.154, issue.3, pp.479-489, 1997.
DOI : 10.1177/37.4.2647838

H. Mcneil and I. Gotis-graham, Human mast cell subsets - distinct functions in inflammation?, Inflammation Research, vol.49, issue.1, pp.3-7, 2000.
DOI : 10.1007/PL00012386

N. Olsson, A. Ulfgren, and G. Nilsson, Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients, Annals of the Rheumatic Diseases, vol.60, issue.3, pp.187-193, 2001.
DOI : 10.1136/ard.60.3.187

M. Buckley, C. Walters, and W. Wong, -tryptase, Histamine and Eosinophil Cationic Protein in Synovial Fluid, Clinical Science, vol.93, issue.4, pp.363-370, 1997.
DOI : 10.1042/cs0930363

A. Hueber, D. Asquith, and A. Miller, Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium, The Journal of Immunology, vol.184, issue.7, pp.3336-3340, 2010.
DOI : 10.4049/jimmunol.0903566

T. Noordenbos, N. Yeremenko, and I. Gofita, Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis, Arthritis & Rheumatism, vol.45, issue.1, pp.99-109, 2012.
DOI : 10.1093/rheumatology/kel365

D. Moulin, O. Donzé, and D. Talabot-ayer, Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells, Cytokine, vol.40, issue.3, pp.216-225, 2007.
DOI : 10.1016/j.cyto.2007.09.013

J. Suurmond, F. Rivellese, and A. Dorjée, Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies, Annals of the Rheumatic Diseases, vol.147, issue.10, pp.2014-205562, 2014.
DOI : 10.1016/j.cytogfr.2005.03.005

J. Suurmond, J. Van-heemst, and J. Van-heiningen, T cells through antigen-dependent interactions, European Journal of Immunology, vol.94, issue.7, pp.1758-1768, 2013.
DOI : 10.1073/pnas.0913054107

S. Nakae, H. Suto, and M. Kakurai, Mast cells enhance T cell activation: Importance of mast cell-derived TNF, Proceedings of the National Academy of Sciences, vol.184, issue.4, pp.6467-6472, 2005.
DOI : 10.1084/jem.184.4.1397

D. Baram, G. Vaday, and P. Salamon, Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-??, The Journal of Immunology, vol.167, issue.7, pp.4008-4016, 2001.
DOI : 10.4049/jimmunol.167.7.4008

J. Suurmond, D. Van-der-velden, and J. Kuiper, Mast cells in rheumatic disease, European Journal of Pharmacology, vol.778, 2015.
DOI : 10.1016/j.ejphar.2015.03.085

N. Magarinos, K. Bryant, and A. Fosang, Mast Cell-Restricted, Tetramer-Forming Tryptases Induce Aggrecanolysis in Articular Cartilage by Activating Matrix Metalloproteinase-3 and -13 Zymogens, The Journal of Immunology, vol.191, issue.3, pp.1404-1412, 2013.
DOI : 10.4049/jimmunol.1300856

S. Seitz, F. Barvencik, and T. Koehne, Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis, Osteoporosis International, vol.15, issue.Suppl 1, pp.2325-2334, 2013.
DOI : 10.1359/jbmr.2000.15.1.13

B. Bader-meunier, C. Livideanu, and C. Larroche, Association of mastocytosis with inflammatory joint diseases: A series of 31 patients, Seminars in Arthritis and Rheumatism, vol.44, issue.3, pp.362-365, 2014.
DOI : 10.1016/j.semarthrit.2014.05.016

K. Eklund, Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy, Immunological Reviews, vol.116, issue.1, pp.38-52, 2007.
DOI : 10.1016/j.bbrc.2006.06.052